About: Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
Creator	Sun, Qing-Feng Zheng, Ming-Hua Gao, Feng George, Jacob George, »more»
source	Medline; PMC
abstract	BACKGROUND AND AIM: Coronavirus disease 2019 (COVID‐19) has attracted increasing worldwide attention. While diabetes is known to aggravate COVID‐19 severity, it is not known whether nondiabetic patients with metabolic dysfunction are also more prone to more severe disease. The association of metabolic associated fatty liver disease (MAFLD) with COVID‐19 severity in nondiabetic patients was investigated here. METHODS: The study cohort comprised 65 patients with (i.e. cases) and 65 patients without MAFLD (i.e. controls). Each case was randomly matched with one control by sex (1:1) and age (±5 years). The association between the presence of MAFLD (as exposure) and COVID‐19 severity (as the outcome) was assessed by binary logistic regression analysis. RESULTS: In nondiabetic patients with COVID‐19, the presence of MAFLD was associated with a four‐fold increased risk of severe COVID‐19; the risk increased with increasing numbers of metabolic risk factors. The association with COVID‐19 severity persisted after adjusting for age, sex, and coexisting morbid conditions. CONCLUSION: Health‐care professionals caring for nondiabetic patients with COVID‐19 should be cognizant of the increased likelihood of severe COVID‐19 in patients with MAFLD.
has issue date	2020-06-05(xsd:dateTime)
bibo:doi	10.1111/jgh.15112
bibo:pmid	32436622
has license	no-cc
sha1sum (hex)	719582a1fb97b97835a032863d9469ceab143273
schema:url	https://doi.org/10.1111/jgh.15112
resource representing a document's title	Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
has PubMed Central identifier	PMC7280625
has PubMed identifier	32436622
schema:publication	J Gastroenterol Hepatol
resource representing a document's body	covid:719582a1fb97b97835a032863d9469ceab143273#body_text
is schema:about of	named entity 'severe' named entity 'metabolic' named entity 'patients' named entity 'COVID-19' named entity 'Coronavirus disease 2019' »more»

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software